Consequently, we suggest truncating MT-ATP6 mutations should be excluded in patients presenting with a MERRF-like phenotype if genetic analysis for more well-recognized causes, such as the m.8344A>G mutation, are negative. Here, MT-ATP6 is linked to MERRF.